Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options Which non FDA (United States Food and Drug Administration) approved peptides, such as BPC 157 (Body Protection Compound 157) and TB 500 (Thymosin Beta 500), are likely legitimate for medical use under strict supervision?